Literature DB >> 10807923

Interaction of inhibitor-2 with the catalytic subunit of type 1 protein phosphatase. Identification of a sequence analogous to the consensus type 1 protein phosphatase-binding motif.

J Yang1, T D Hurley, A A DePaoli-Roach.   

Abstract

Inhibitor-2 (I-2) is the regulatory subunit of a cytosolic type 1 Ser/Thr protein phosphatase (PP1) and potently inhibits the activity of the free catalytic subunit (CS1). Previous work from the laboratory had proposed that the interaction of I-2 with CS1 involved multiple sites (Park, I. K., and DePaoli-Roach, A. A. (1994) J. Biol. Chem. 269, 28919-28928). The present study refines the earlier analysis and arrives at a more detailed model for the interaction between I-2 and CS1. Although the NH(2)-terminal I-2 regions containing residues 1-35 and 1-64 have no inhibitory activity on their own, they increase the IC(50) for I-2 by approximately 30-fold, indicating the presence of a CS1-interacting site. Based on several experimental approaches, we have also identified the sequence Lys(144)-Leu-His-Tyr(147) as a second site of interaction that corresponds to the RVXF motif present in many CS1-binding proteins. The peptide I-2(135-151) significantly increases the IC(50) for I-2 and attenuates CS1 inhibition. Replacement of Leu and Tyr with Ala abolishes the ability to counteract inhibition by I-2. The I-2(135-151) peptide, but not I-2(1-35), also antagonizes inhibition of CS1 by DARPP-32 in a pattern similar to that of I-2. Furthermore, a peptide derived from the glycogen-binding subunit, R(GL)/G(M)(61-80), which contains a consensus CS1-binding motif, completely counteracts CS1 inhibition by I-2 and DARPP-32. The NH(2)-terminal 35 residues of I-2 bind to CS1 at a site that is specific for I-2, whereas the KLHY sequence interacts with CS1 at a site shared with other interacting proteins. Other results suggest the presence of yet more sites of interaction. A model is presented in which multiple "anchoring interactions" serve to position a segment of I-2 such that it sterically occludes the catalytic pocket but need not make high affinity contacts itself.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10807923     DOI: 10.1074/jbc.M003082200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  12 in total

1.  Type 1 phosphatase, a negative regulator of cardiac function.

Authors:  Andrew N Carr; Albrecht G Schmidt; Yoichi Suzuki; Federica del Monte; Yoji Sato; Carita Lanner; Kristine Breeden; Shao-Ling Jing; Patrick B Allen; Paul Greengard; Atsuko Yatani; Brian D Hoit; Ingrid L Grupp; Roger J Hajjar; Anna A DePaoli-Roach; Evangelia G Kranias
Journal:  Mol Cell Biol       Date:  2002-06       Impact factor: 4.272

Review 2.  The role of serine/threonine protein phosphatases in exocytosis.

Authors:  Alistair T R Sim; Monique L Baldwin; John A P Rostas; Jeff Holst; Russell I Ludowyke
Journal:  Biochem J       Date:  2003-08-01       Impact factor: 3.857

3.  Successful overexpression of wild-type inhibitor-2 of PP1 in cardiovascular cells.

Authors:  Thorsten Krause; Stefanie Grote-Wessels; Felix Balzer; Peter Boknik; Ulrich Gergs; Uwe Kirchhefer; Igor B Buchwalow; Frank U Müller; Wilhelm Schmitz; Joachim Neumann
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2018-05-24       Impact factor: 3.000

4.  Laforin, a dual specificity phosphatase that dephosphorylates complex carbohydrates.

Authors:  Carolyn A Worby; Matthew S Gentry; Jack E Dixon
Journal:  J Biol Chem       Date:  2006-08-10       Impact factor: 5.157

5.  Insulin control of glycogen metabolism in knockout mice lacking the muscle-specific protein phosphatase PP1G/RGL.

Authors:  Y Suzuki; C Lanner; J H Kim; P G Vilardo; H Zhang; J Yang; L D Cooper; M Steele; A Kennedy; C B Bock; A Scrimgeour; J C Lawrence; A A DePaoli-Roach
Journal:  Mol Cell Biol       Date:  2001-04       Impact factor: 4.272

6.  Detailed structural characterization of unbound protein phosphatase 1 inhibitors.

Authors:  Barbara Dancheck; Angus C Nairn; Wolfgang Peti
Journal:  Biochemistry       Date:  2008-11-25       Impact factor: 3.162

7.  Selective targeting of the gamma1 isoform of protein phosphatase 1 to F-actin in intact cells requires multiple domains in spinophilin and neurabin.

Authors:  Leigh C Carmody; Anthony J Baucum; Martha A Bass; Roger J Colbran
Journal:  FASEB J       Date:  2008-01-23       Impact factor: 5.191

8.  Plasmodium falciparum encodes a conserved active inhibitor-2 for Protein Phosphatase type 1: perspectives for novel anti-plasmodial therapy.

Authors:  Aline Fréville; Katia Cailliau-Maggio; Christine Pierrot; Géraldine Tellier; Hadidjatou Kalamou; Sophia Lafitte; Alain Martoriati; Raymond J Pierce; Jean-François Bodart; Jamal Khalife
Journal:  BMC Biol       Date:  2013-07-09       Impact factor: 7.431

9.  Role of PP1 in the regulation of Ca cycling in cardiac physiology and pathophysiology.

Authors:  Persoulla Nicolaou; Evangelia G Kranias
Journal:  Front Biosci (Landmark Ed)       Date:  2009-01-01

10.  Identification and characterization of two distinct PPP1R2 isoforms in human spermatozoa.

Authors:  Luis Korrodi-Gregório; Mónica Ferreira; Ana Paula Vintém; Wenjuan Wu; Thorsten Muller; Katrin Marcus; Srinivasan Vijayaraghavan; David L Brautigan; Odete A B da Cruz E Silva; Margarida Fardilha; Edgar F da Cruz E Silva
Journal:  BMC Cell Biol       Date:  2013-03-18       Impact factor: 4.241

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.